Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Debt Ratio (2017 - 2026)

Ani Pharmaceuticals' Debt Ratio history spans 11 years, with the latest figure at 0.21 for Q4 2025.

  • On a quarterly basis, Debt Ratio fell 13.39% to 0.21 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.21, a 13.39% decrease, with the full-year FY2025 number at 0.21, down 13.39% from a year prior.
  • Debt Ratio hit 0.21 in Q4 2025 for Ani Pharmaceuticals, down from 0.22 in the prior quarter.
  • Over the last five years, Debt Ratio for ANIP hit a ceiling of 0.43 in Q3 2021 and a floor of 0.21 in Q4 2025.
  • Historically, Debt Ratio has averaged 0.33 across 5 years, with a median of 0.34 in 2023.
  • Biggest five-year swings in Debt Ratio: increased 5.67% in 2021 and later dropped 24.36% in 2025.
  • Tracing ANIP's Debt Ratio over 5 years: stood at 0.37 in 2021, then grew by 0.91% to 0.38 in 2022, then fell by 15.96% to 0.32 in 2023, then dropped by 21.55% to 0.25 in 2024, then fell by 13.39% to 0.21 in 2025.
  • Business Quant data shows Debt Ratio for ANIP at 0.21 in Q4 2025, 0.22 in Q3 2025, and 0.23 in Q2 2025.